Tenofovir Alafenamide Shortage Update: What Patients Need to Know in 2026

Updated:

March 13, 2026

Author:

Peter Daggett

Summarize this blog with AI:

Is Tenofovir Alafenamide (Vemlidy) in shortage in 2026? Get the latest update on availability, cost, and what hepatitis B patients can do right now.

Tenofovir Alafenamide in 2026: What's Really Going On?

If you take Tenofovir Alafenamide (brand name Vemlidy) for chronic hepatitis B, you may have heard conflicting information about whether it's in shortage. Maybe your pharmacy couldn't fill your prescription, or you've seen mentions of supply issues online. Let's cut through the noise and give you a clear picture of what's happening with Tenofovir Alafenamide availability in 2026.

Is Tenofovir Alafenamide Currently in Shortage?

As of early 2026, Vemlidy (Tenofovir Alafenamide) is not listed on the FDA's official drug shortage database as a standalone product. However, that doesn't tell the whole story.

Many patients are reporting difficulty finding Vemlidy at their local pharmacies. This isn't necessarily a manufacturing shortage — it's more of an availability and access problem. The reality is that many pharmacies simply don't stock Vemlidy routinely because it's a high-cost specialty medication with a relatively small patient base.

Additionally, some TAF-containing HIV combination products like Biktarvy and Descovy have experienced periodic supply constraints, which can create uncertainty across the broader TAF supply chain.

Why Is It So Hard to Find?

Several factors are contributing to the difficulty patients face when trying to fill their Vemlidy prescriptions:

No US Generic Available

Despite FDA approval for generic manufacture, no generic Tenofovir Alafenamide is currently marketed in the United States. A generic combination product (Emtricitabine/TAF) was authorized in the European Union in 2025, but this hasn't translated to US availability yet. Without generic competition, supply remains limited to Gilead's brand product.

Specialty Medication Stocking Patterns

Vemlidy costs approximately $1,500 to $1,800 per month without insurance. Many retail pharmacies, especially chains, don't keep expensive specialty medications on their shelves unless they have regular customers who need them. This means your pharmacy might need to special-order it, which can take several days.

Insurance and Distribution Restrictions

Some insurance plans require patients to use specialty pharmacies or mail-order services for Vemlidy, rather than retail pharmacies. If your prescription is sent to a pharmacy that isn't in your plan's specialty network, it may appear as if the drug is "unavailable" when the issue is actually an insurance routing problem.

What Does Tenofovir Alafenamide Cost in 2026?

Understanding the cost picture can help you navigate your options:

  • Brand Vemlidy (cash price): Approximately $1,500-$1,800 for a 30-day supply
  • With commercial insurance: Co-pays vary widely, from $0 to several hundred dollars depending on your plan's formulary tier
  • Gilead co-pay assistance: Eligible commercially insured patients may pay as little as $0 per month
  • Gilead Advancing Access (uninsured): Free medication for qualifying patients

For detailed savings strategies, read our complete guide on how to save money on Tenofovir Alafenamide.

Are There New Options in 2026?

While the landscape for hepatitis B treatment hasn't seen a dramatic shift recently, there are a few developments worth noting:

  • Generic TAF combinations in the EU: The approval of generic Emtricitabine/TAF in the European Union in 2025 is a step toward broader generic access, though US availability remains uncertain.
  • Pipeline treatments: Several new hepatitis B treatments are in clinical trials, including functional cure approaches. While these aren't available yet, they represent hope for the future.
  • Established alternatives: Medications like Entecavir and Tenofovir Disoproxil Fumarate remain widely available and effective. Read about alternatives to Tenofovir Alafenamide.

How to Find Tenofovir Alafenamide in Stock

Here are your best options for locating Vemlidy right now:

  1. Use Medfinder to search for real-time pharmacy availability in your area
  2. Contact specialty pharmacies — they're more likely to stock or quickly order Vemlidy
  3. Ask about mail-order options through your insurance plan
  4. Call independent pharmacies — they often have more flexible ordering capabilities
  5. Talk to your doctor's office — they may have connections to specialty pharmacy networks

For a detailed walkthrough, see our post on how to find Tenofovir Alafenamide in stock near you.

Final Thoughts

Tenofovir Alafenamide isn't in a formal FDA-declared shortage, but real-world access challenges mean many patients are struggling to get their prescriptions filled. The combination of high cost, no US generic, and limited pharmacy stocking creates a frustrating situation for people who depend on this medication.

Stay proactive: use tools like Medfinder, explore financial assistance programs, and keep your doctor informed about any access issues. Your hepatitis B treatment is essential, and there are paths to keeping it on track.

For more information about this medication, explore our guides on what Tenofovir Alafenamide is, side effects to watch for, and drug interactions to avoid.

Is Tenofovir Alafenamide on the FDA shortage list in 2026?

As of early 2026, Vemlidy (Tenofovir Alafenamide) is not listed on the FDA's official drug shortage database as a standalone product. However, many patients report difficulty finding it at retail pharmacies due to limited stocking of this specialty medication.

Why can't my pharmacy get Tenofovir Alafenamide?

Most pharmacies don't routinely stock Vemlidy because it's a high-cost specialty medication ($1,500-$1,800/month) with a relatively small patient base. There is also no US-marketed generic available. Try specialty pharmacies, independent pharmacies, or mail-order services instead.

Will a generic version of Tenofovir Alafenamide be available soon?

The FDA has approved generic manufacture of Tenofovir Alafenamide, but no generic is currently marketed in the US. A generic combination product was authorized in the EU in 2025. The timeline for US generic availability remains uncertain.

What happens if I miss doses of Tenofovir Alafenamide due to a shortage?

Missing doses can allow the hepatitis B virus to rebound, and stopping suddenly carries a risk of severe hepatitis B flare-ups (this is an FDA boxed warning). Contact your doctor immediately if you're at risk of running out so they can arrange alternatives or help locate your medication.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast-turnaround time
Never call another pharmacy